Julie Ervin, Bsn, Rn
About Julie Ervin, Bsn, Rn
Julie Ervin, BSN, RN, serves as a Clinical Research Nurse III at the National Institutes of Health, specializing in patient populations with rare genetic disorders. With a background that includes roles in various healthcare settings, she has significant experience in complex therapies and actively pursues further training in clinical research.
Current Role at National Institutes of Health
Julie Ervin serves as a Clinical Research Nurse III at the National Institutes of Health, a position she has held since 2020. In this role, she specializes in managing patient populations with rare genetic disorders, including conditions such as Cushing's disease. Her work involves overseeing clinical trials and ensuring the safety and well-being of participants. Julie actively seeks to enhance her expertise in clinical research and trials through additional training and employment opportunities.
Previous Experience in Healthcare
Prior to her current position, Julie Ervin accumulated diverse nursing experience across several healthcare organizations. She worked as a Travel Registered Nurse at Medical Solutions for three months in New Haven, Connecticut, in 2019. Additionally, she served as a Rehabilitation Therapeutic Technician at Christiana Care Health System for eight months in 2013. Julie also held various roles at LifeBridge Health, including Registered Nurse positions from 2017 to 2020, and worked as a Nursing Assistant/Student Nurse at the University of Maryland Medical Center from 2012 to 2016.
Education and Training
Julie Ervin earned her Bachelor of Science in Nursing from the University of Delaware, where she studied from 2011 to 2016. During her academic career, she also pursued a minor in Human Development and Family Studies. This educational background has equipped her with the foundational knowledge and skills necessary for her nursing practice and her specialization in clinical research.
Specialization in Rare Genetic Disorders
Julie Ervin specializes in managing patient populations with rare genetic disorders. Her expertise extends to complex therapies, including CAR T-cell therapy and gene therapy, particularly in pediatric patients. This specialization reflects her commitment to advancing care for individuals with unique medical needs and her focus on innovative treatment approaches.